Esofagitis eosinofílica: estado actual DOI Creative Commons
Edison Muñoz-Ortiz, Fabián Juliao Baños

IATREIA, Год журнала: 2012, Номер 26(1)

Опубликована: Ноя. 21, 2012

La esofagitis eosinofílica es una infiltración del esófago por eosinófilos, presumiblemente de origen alérgico, que se presenta en niños y adultos. En estos últimos más frecuente hombres edad media su característica clínica principal la disfagia. El conocimiento esta enfermedad ha tenido gran desarrollo los 10 años con mejor entendimiento fisiopatología estudios buscan evaluar diferentes alternativas tratamiento. Se revisión literatura describen epidemiología, manifestaciones clínicas, fisiopatología, diagnóstico diferencial opciones terapéuticas enfermedad.

Eosinophilic Esophagitis Masquerading as Steakhouse Syndrome: A Case Report DOI Creative Commons
Emanuel‐Youssef Dib,

Jessy Fadel,

Karam Karam

и другие.

Medical Reports, Год журнала: 2025, Номер unknown, С. 100176 - 100176

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Diagnosis, management and therapeutic options for eosinophilic esophagitis DOI
Marco Caminati, Gianenrico Senna,

Matteo Maule

и другие.

Current Opinion in Allergy and Clinical Immunology, Год журнала: 2024, Номер 24(3), С. 122 - 128

Опубликована: Апрель 24, 2024

Purpose of review Eosinophilic esophagitis is a chronic and commonly evolving condition leading to relevant potentially irreversible burden in terms tissue damage related functional impairment, thus significantly impacting on quality life. The aim the present summarize recent advances diagnostic work-up pharmacological nonpharmacological management disease, under broader perspective type 2 inflammation. Recent findings Two major novelties have prompted an innovative approach EoE. In diagnosis, it has been proposed dissect disease heterogeneity three endotypes, independent from eosinophil number: EoEe1, characterized by normal appearing oesophagus; EoEe2, associated with inflammation steroid-refractoriness; EoEe3, whose features include adult onset, more fibro-stenotic aspect loss epithelial gene expression. Concerning treatment, two recently licensed drugs for EoE, oro-dispersible budesonide dupilumab represent first treatment options specifically developed EoE addressing EoE-related peculiar pathobiological features. Summary era precision medicine, managing according phenotype-driven might be helpful defining best different forms or stages. addition, exploring coexistence previous occurrence other conditions may suggest opportunity target through biologic therapy. complex pathobiology combining inflammatory features, both at organ systemic level, requires multidimensional relying strict integration gastroenterologists allergist-immunologists.

Язык: Английский

Процитировано

3

Mononuclear cell composition and activation in blood and mucosal tissue of eosinophilic esophagitis DOI Creative Commons

Eva Gruden,

Melanie Kienzl,

Dušica Ristić

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Янв. 22, 2024

Eosinophilic esophagitis (EoE) is a chronic, inflammatory, antigen-driven disease of the esophagus. Tissue EoE pathology has previously been extensively characterized by novel transcriptomics and proteomic platforms, however majority surface marker determination screening performed in blood due to mucosal tissue size limitations. While eosinophils, CD4+ T cells, mast cells natural killer (NK) were investigated context EoE, an accurate picture composition peripheral mononuclear (PBMC) their activation missing. In this study, we aimed comprehensively analyze using measurements with multicolor flow cytometry simultaneously both patients active inactive gastroesophageal reflux (GERD) controls. Moreover, set out validate our data co-cultures PBMC human primary esophageal epithelial inducible mouse model eosinophilic esophagitis, extensive IL-33 secretion Our results indicate that specific populations are enriched, they alter expression markers EoE. particular, observed upregulation immunomodulatory molecule CD38 on myeloid biopsies significant PD-1 which was even more prominent after corticosteroid treatment. With co-culture experiments could demonstrate direct cell contact needed for cells. Finally, validated findings Herein show alterations profile comparison GERD controls, have potential implications To knowledge, study first its kind expanding multi-color approach different patient groups vitro vivo translational models.

Язык: Английский

Процитировано

2

Eosinophilic Gastrointestinal Disease DOI
Monica Soni, Kathryn A. Peterson, Amiko M. Uchida

и другие.

JAMA, Год журнала: 2024, Номер 331(16), С. 1407 - 1407

Опубликована: Март 25, 2024

This JAMA Insights Clinical Update discusses the symptoms, diagnosis, and management of eosinophilic gastrointestinal diseases.

Язык: Английский

Процитировано

2

Minimally Invasive Approaches to Diagnose and Monitor Eosinophilic GI Diseases DOI

Ellie J. M. Furuta,

Glenn T. Furuta, Robin Shandas

и другие.

Current Allergy and Asthma Reports, Год журнала: 2024, Номер 24(5), С. 269 - 279

Опубликована: Март 27, 2024

Язык: Английский

Процитировано

1

Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment DOI Creative Commons
Lola Ugalde‐Triviño, Francisca Molina‐Jiménez, Juan H-Vázquez

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Апрель 5, 2024

Objectives The aim of the study was to characterize circulating immunome patients with EoE before and after proton pump inhibitor (PPI) treatment in order identify potential non-invasive biomarkers response. Methods PBMCs from 19 healthy controls 24 were studied using a 39-plex spectral cytometry panel. plasmacytoid dendritic cell (pDC) population differentially characterized by analysis immunofluorescence assays esophageal biopsies 7 13 patients. Results Interestingly, at baseline had lower levels pDC compared controls. Before treatment, who responded PPI therapy higher classical monocytes, non-responders. Moreover, following increased all patients, while normal only restored PPI-responding Finally, inversely correlated peak eosinophil count biopsies. number tissue pDCs significantly during active EoE, being even non-responder when responder pre-PPI. decreased intake, further almost control post-PPI. Conclusions We hereby describe unique immune fingerprint diagnosis. may be also used as novel biomarker predict subsequent response treatment.

Язык: Английский

Процитировано

1

Satisfaction With and Adherence to Off-Label Corticosteroids in Adolescents and Adults With Eosinophilic Esophagitis DOI Creative Commons

Benjamin D. Gold,

Bridgett Goodwin,

Kimberly Davis

и другие.

Journal of Clinical Gastroenterology, Год журнала: 2024, Номер unknown

Опубликована: Май 15, 2024

Goals: We assessed satisfaction with and adherence to off-label corticosteroids in patients eosinophilic esophagitis (EoE) the United States. Background: EoE is a chronic inflammatory disease for which there are currently no US Food Drug Administration-approved swallowed topical corticosteroids. Study: This noninterventional, cross-sectional, web-based survey included caregivers of adolescents (aged 11 17 y) adults 18 years or older) self-reported [or caregiver-reported (adolescents)] physician diagnosis who were receiving Participants recruited through 2 nonprofit, patient advocacy groups. The 9-item Treatment Satisfaction Questionnaire Medication (TSQM-9) was used assess across effectiveness, convenience, global domains (scale: 1 100 per domain); higher scores indicated greater satisfaction. 4-item Morisky Green Levine Adherence Scale (MGL-4) adherence; an MGL-4 score <3 adherence. also reported reasons nonadherence. Results: Overall, 201 participants (caregivers adolescents, n=98; adults, n=103) this study. Mean TSQM-9 low all 3 (≤61.1) (≤55.7). Slightly fewer (37.1%) than (40.8%) considered adherent. Forgetfulness most frequently reason nonadherence; some chose not take their medications, owing poor palatability (adolescents), difficulty taking medications at specific times (adults), feeling depressed/overwhelmed (adolescents adults). Conclusions:

Язык: Английский

Процитировано

1

Standardizing visual display of gastrointestinal pathology results for improved clinical interpretation DOI Creative Commons
Jeannie S. Huang,

Ann M. Lindgren,

David J. Katibian

и другие.

Journal of Pediatric Gastroenterology and Nutrition, Год журнала: 2024, Номер 79(3), С. 550 - 557

Опубликована: Авг. 1, 2024

Pathology is an essential component of disease diagnosis and management in pediatric gastroenterology. reports have not been standardized some areas gastrointestinal pathology reporting varies. Development electronic medical record (EMR) synoptic report templates (PSRT) enables data collection a specific format can help standardize reporting. We developed, implemented, evaluated EMR PSRTs for eosinophilic esophagitis (EoE) inflammatory bowel (IBD).

Язык: Английский

Процитировано

1

Da etiopatogênese as estratégias terapêuticas: uma revisão integrativa da literatura sobre a esofagite eosinofílica DOI Creative Commons

Hugo Caldas Torres,

Leonardo Lopes Jatobá Tenório,

Ana Paula Fernandes da Silva

и другие.

Revista JRG de Estudos Acadêmicos, Год журнала: 2024, Номер 7(14), С. e141190 - e141190

Опубликована: Июнь 7, 2024

Uma condição recentemente identificada que incorpora este conceito é a Esofagite Eosinofílica (EE). Esta afecção caracterizada por inflamação de longa duração do esôfago, marcada um grande número eosinófilos na mucosa proximal e distal. Isto pode ou não ser acompanhado refluxo gastroesofágico. Desta forma, seguinte pesquisa tem objetivo compreender sintetizar informações desde os aspectos etiológicos até as estratégias terapêuticas, proporcionando uma visão holística atualizada dessa médica. Trata-se revisão integrativa, resultou em 12 artigos para análise desta revisão. Os resultados apontam que, indivíduos com predisposição genética podem apresentar infiltração da esofágica componentes granulocíticos, especificamente basófilos, como resultado consumo certos alimentos leite trigo. Um dos benefícios das dietas opção terapêutica elas eliminam necessidade depender medicamentos crônicos controlar doença. IBPs são escolha eficaz o tratamento farmacológico EE, quer sejam utilizados isoladamente combinação outras terapias. Consequentemente, crucial enfatizar importância realização mais pesquisas, incluindo ensaios clínicos randomizados, determinar eficazes podem, última análise, melhorar sintomas bem-estar nutricional pacientes.

Процитировано

0

Phenotype of eosinophilic esophagitis with outcome in stenosis in children: a series of clinical cases DOI Open Access
S.S. Vyazankina, T.N. Budkina,

Maxim Lokhmatov

и другие.

Russian Pediatric Journal, Год журнала: 2024, Номер 27(3), С. 218 - 227

Опубликована: Июль 12, 2024

Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease characterized by esophageal dysfunction due to prolonged eosinophilic infiltration of tissues. In recent years, there has been tendency increase the prevalence EoE, which may lead an in detection strictures children. Aim: determine clinical features phenotype with outcome stenosis Materials and methods. Seventy children diagnosed EoE were examined, 9 (12.86%) them had stenosis. The average age manifestation was 6.17 years. analysis series cases carried out describe disease. At same time, characteristics patients data from laboratory instrumental examination methods, including esophagogastroduodenoscopy biopsy, used. Results. examined patients, delay diagnosis averaged 3 years after appearance first symptoms. Early manifestations EOE are discomfort when swallowing need grind food. most common concomitant gastroenterological gastroesophageal reflux (GER). All food allergies, 55 (77.8%) allergic cow’s milk proteins (ACMP). Esophageal more often local, lower or middle third. Inflammatory changes mucous membrane (MM) esophagus detected all patients; ring-type disorders noted 47 (66.7%) patients. median maximum number eosinophils MM 30 per 0.3 mm2. Subepithelial fibrosis observed 16 (22.2%) 62 (88.9%) stopped against background conservative treatment. Conclusion. Increasing awareness necessary reduce time for diagnosis, timely treatment risk complications form

Язык: Английский

Процитировано

0